ALKERMES | Resultat Før Skat



Pre Tax Profit Lave om Dato
AbbVie USD 4.81B 1.54B 2024-12
Acadia Pharmaceuticals USD 161.08M 122.28M 2024-12
ALKERMES USD 443.75M 333.52M 2024-12
Amgen USD 3.38B 111M 2024-12
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Eli Lilly USD 3.46B 2.08B 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
Ionis Pharmaceuticals USD -147000000 40M 2025-03
J&J USD 13.63B 8.21B 2025-03
Merck USD 5.22B 114M 2024-12
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Otsuka Holdings JPY 113.37B 33.53B 2025-03
Pfizer USD 4.44B 2.36B 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



ALKERMES Resultat Før Skat - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.